期刊文献+

非血缘异基因造血干细胞移植治疗幼年型粒-单核细胞型白血病一例并文献复习 被引量:2

原文传递
导出
摘要 目的 探讨幼年型粒-单核细胞型白血病(JMML)的临床特点及治疗方法.方法 回顾性分析1例JMML患者的临床特点及其治疗经过.结果 患者完善各项检查后明确诊断为JMML,给予非血缘异基因造血干细胞移植后顺利造血重建,无病生存(移植后9个月余).结论 JMML是一种罕见的克隆性造血干细胞增生异常性疾病,具有其独特的临床特点,但易被忽视而误诊;JMML预后较差,骨髓移植是唯一可以延长生存期的有效方法.
出处 《白血病.淋巴瘤》 CAS 2013年第10期621-623,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献21

  • 1tlasle H, Wadsworth LD, Massing BG, et el. A population based study of childhood myelodysplastic syndrome in Bristish Columbia, Canada. Br J Haematol, 1999, 106: 1027-1032.
  • 2Luna-Fineman S, Shannon KM,Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood, 1999, 93: 459-466.
  • 3Castro-Melaspina H, Schaison G, Pasquier A, et al. Suhacute and chronic myelomonocytie leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer, 1984, 54: 675-686.
  • 4Chan RJ, Cooper T, Kratz CP, et al. Juvenile myelomonocytic leukemia: a report from the 2nd Intefnationel JMML Symposium. Leuk Res, 2009, 33: 355-362.
  • 5Loh ML, Sakai DS, Flotho C, et el. Mutations in CBL occur frequently in juvenile mydomonocytic leukemia. Blood, 2009, 114:1859-1863.
  • 6Suda T, Miura Y, Mizoguchi H, et al. Characterization of hemopoietic precursor cells in junvenile type chronic myelocytic leukemia. Leuk Res, 1982, 6: 43-53.
  • 7Ninemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysp lastic Syndromes in Childhood. Blood, 1997, 89: 3534-3543.
  • 8Woods WG, Barnard DR, Alonzo TA, et el. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastie syndrome: a report from the Children's Cancer Group. J Clin Oncol, 2002, 20: 434-440.
  • 9Bergstraesser E, Hasle H, Rogge T, et el. Non-hematopoietic stem cell transplantation treatment of juvenile myelomon0cytic leukemia: a retrospective analysis mad definition of response criteria. Pediatr BloodCancer, 2007, 49: 629-633.
  • 10Kratz CP, Niemeyer CM, Castleherry RP, et al. The mutational spectrum of FFPNI1 in juvenile myelomonocytic leukemia nd Noonan syndrome/myeloproliferative disease. Blood, 2005, 106:2183- 2185.

二级参考文献19

  • 1Gluckman E,Rocha V,Boyer-Chammard A,et al.Outcome of cord blood transplantation from related and unrelated donors.Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.N Engl J Med,1997,337:373-381.
  • 2Rubinstein P,Carrier C,Scaradavou A,et al.Outcomes among 562 recipients of placental blood transplants from unrelated donors.New Engl J Med,1998,39:1565-1577.
  • 3Nabhan S,Rocha V,Arcese W,et al.Influence of Myeloablative Conditioning Regimens on Outcomes after Single Unrelated Cord Blood Transplantation for Adults with Leukemia: An Analysis on Behalf of Eurocord-EBMT-Netcord-Blood.Blood,2008,112:155(Abstract).
  • 4Locatelli F,Rocha V,Reed W,et al.Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.Blood,2003,101:2137-2143.
  • 5Eapen M,Rubinstein P,Zhang MJ,et al.Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia:a comparison study.Lancet,2007,369:1947-1954.
  • 6Barker JN,Scaradavou A,Stevens CA,eta.Combined effect of total nucleated cell dose.and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.Blood,2010,115:1843-1849.
  • 7Rocha V.Clinical results of unrelated cord blood transplantation.Hematology education,the Education program for the 16th Congress of the European Hematology Association.2011:56-63.
  • 8Brunstein CG, Gutman JA, Weisdorf DJ, et al. Allogeneic hematopoietic cell transplantation for hematological malignancy:relative risks and benefits of double umbilical cord blood.Blood,2010,116:4693-4699.
  • 9Brunstein CG,Barker JN,Weisdorf DJ,et al.Umbilical cord blood transplantation after nonmyeloablative conditioning:impact on transplantation outcomes in 110 adults with hematologic disease.Blood,2007,110:3064-3070.
  • 10Rio B,Furst S,Renaud M,et al.Encouraging results of unrelated cord blood transplantation (UCBT) after homogenous reduced intensity conditioning (RIC) in adults with hematological malignancy:impact of HLA disparities on outcomes.A French multicentre study on behalf of the SFGM-TC and Eurocord.Bone Marrow Transplant,2009,43:S10.

共引文献5

同被引文献14

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部